These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 22258814)
1. Survivin-mediated therapeutic efficacy of gemcitabine through glucose-regulated protein 78 in hepatocellular carcinoma. Hung CS; Lin SF; Liu HH; Kuo LJ; Li LT; Su HY; Liew PL; Lin FY; Wei PL; Liu DZ; Chang YJ Ann Surg Oncol; 2012 Aug; 19(8):2744-52. PubMed ID: 22258814 [TBL] [Abstract][Full Text] [Related]
2. Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma. Chang YJ; Tai CJ; Kuo LJ; Wei PL; Liang HH; Liu TZ; Wang W; Tai CJ; Ho YS; Wu CH; Huang MT Ann Surg Oncol; 2011 Aug; 18(8):2395-403. PubMed ID: 21347788 [TBL] [Abstract][Full Text] [Related]
3. Knockdown survivin expression reduces the efficacy of curcumin treatment in hepatocellular carcinoma cells. Hung CS; Liu HH; Huang MT; Cheng CW; Kuo LJ; Ho YS; Wu CH; Chen CM; Wei PL; Chang YJ Ann Surg Oncol; 2012 Oct; 19(11):3547-55. PubMed ID: 22711176 [TBL] [Abstract][Full Text] [Related]
4. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells. Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372 [TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer. Galloway NR; Aspe JR; Sellers C; Wall NR Pancreas; 2009 Oct; 38(7):782-90. PubMed ID: 19506533 [TBL] [Abstract][Full Text] [Related]
6. Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma. Chiou JF; Tai CJ; Huang MT; Wei PL; Wang YH; An J; Wu CH; Liu TZ; Chang YJ Ann Surg Oncol; 2010 Feb; 17(2):603-12. PubMed ID: 19830497 [TBL] [Abstract][Full Text] [Related]
7. Silencing survivin activates autophagy as an alternative survival pathway in HCC cells. Chang YJ; Li LT; Chen HA; Hung CS; Wei PL Tumour Biol; 2014 Oct; 35(10):9957-66. PubMed ID: 25008566 [TBL] [Abstract][Full Text] [Related]
8. The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin. Srirangam A; Milani M; Mitra R; Guo Z; Rodriguez M; Kathuria H; Fukuda S; Rizzardi A; Schmechel S; Skalnik DG; Pelus LM; Potter DA J Thorac Oncol; 2011 Apr; 6(4):661-70. PubMed ID: 21270666 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells. Huang YT; Cheng CC; Lin TC; Chiu TH; Lai PC Oncol Rep; 2014 Feb; 31(2):771-80. PubMed ID: 24297644 [TBL] [Abstract][Full Text] [Related]
10. Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway. Wu ZH; Lin C; Liu MM; Zhang J; Tao ZH; Hu XC PLoS One; 2016; 11(12):e0169230. PubMed ID: 28036386 [TBL] [Abstract][Full Text] [Related]
11. The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases. Matsumoto K; Nagahara T; Okano J; Murawaki Y Oncol Rep; 2008 Oct; 20(4):863-72. PubMed ID: 18813828 [TBL] [Abstract][Full Text] [Related]
12. Bile salt (glycochenodeoxycholate acid) induces cell survival and chemoresistance in hepatocellular carcinoma. Wang C; Yang M; Zhao J; Li X; Xiao X; Zhang Y; Jin X; Liao M J Cell Physiol; 2019 Jul; 234(7):10899-10906. PubMed ID: 30548625 [TBL] [Abstract][Full Text] [Related]
13. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine. Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804 [TBL] [Abstract][Full Text] [Related]
14. Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression. Fei B; Chi AL; Weng Y World J Surg Oncol; 2013 May; 11():120. PubMed ID: 23721525 [TBL] [Abstract][Full Text] [Related]
15. Novel roles of folic acid as redox regulator: Modulation of reactive oxygen species sinker protein expression and maintenance of mitochondrial redox homeostasis on hepatocellular carcinoma. Lai KG; Chen CF; Ho CT; Liu JJ; Liu TZ; Chern CL Tumour Biol; 2017 Jun; 39(6):1010428317702649. PubMed ID: 28639913 [TBL] [Abstract][Full Text] [Related]
16. siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity. Liu WS; Yan HJ; Qin RY; Tian R; Wang M; Jiang JX; Shen M; Shi CJ Dig Dis Sci; 2009 Jan; 54(1):89-96. PubMed ID: 18594980 [TBL] [Abstract][Full Text] [Related]
17. 16-O-caffeoyl-16-hydroxylhexadecanoic acid, a medicinal plant-derived phenylpropanoid, induces apoptosis in human hepatocarcinoma cells through ROS-dependent endoplasmic reticulum stress. Huang RZ; Huang XC; Zhang B; Jia HY; Liao ZX; Wang HS Phytomedicine; 2018 Mar; 41():33-44. PubMed ID: 29519317 [TBL] [Abstract][Full Text] [Related]
18. 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1, 2-c]quinolin-11-one (BPIQ), A Quinoline Derivative Inhibits Human Hepatocellular Carcinoma Cells by Inducing ER Stress and Apoptosis. Chang WT; Fong Y; Chuang SC; Chou CK; Chou HL; Yang CF; Tseng CH; Chen YL; Chiu CC Anticancer Agents Med Chem; 2017; 17(5):692-700. PubMed ID: 27491935 [TBL] [Abstract][Full Text] [Related]
19. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine]. Liu A; Hu YS; Wang ZH; Tang LL; Ke PY; Lin SZ Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284 [TBL] [Abstract][Full Text] [Related]
20. The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2. Yoon DH; Shin JS; Jin DH; Hong SW; Jung KA; Kim SM; Hong YS; Kim KP; Lee JL; Suh C; Lee JS; Kim TW Anticancer Res; 2012 May; 32(5):1681-8. PubMed ID: 22593446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]